一药企宣布,暂停开发减肥药

康可药研
07 Feb

本文仅供信息分享,不构成用药或治疗或投资推荐。因编辑水平有限,如有错误或不是最新信息感谢指出!减肥药市场风云再起。安进宣布暂停开发减肥药2月4日,安进发布消息,暂停开发减肥药。减肥药是目前市场公认的“明星药物”,招商银行研究院研报数据预计,2030年中国归因于超重/肥胖的医疗费用将达4180亿元。庞大的患者群体带来巨大的市场需求,近些年来减肥药市场火热,尤其是GLP-1类减肥药,自2021年以来其...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10